Revance Therapeutics, Inc. (RVNC)
Feb 6, 2025 = RVNC was delisted (reason: acquired by Crown Laboratories)
3.650
0.00 (0.00%)
Inactive · Last trade price on Feb 6, 2025
Revance Therapeutics Employees
Revance Therapeutics had 597 employees as of December 31, 2023. The number of employees increased by 63 or 11.80% compared to the previous year.
Employees
597
Change (1Y)
63
Growth (1Y)
11.80%
Revenue / Employee
$430,394
Profits / Employee
-$308,943
Market Cap
383.05M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 597 | 63 | 11.80% |
Dec 31, 2022 | 534 | 39 | 7.88% |
Dec 31, 2021 | 495 | 25 | 5.32% |
Dec 31, 2020 | 470 | 277 | 143.52% |
Dec 31, 2019 | 193 | 23 | 13.53% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
RVNC News
- 6 months ago - Rosen Law Firm Urges Revance Therapeutics, Inc. (NASDAQ: RVNC) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
- 6 months ago - RVNC STOCK NEWS: Robbins LLP Reminds Revance Therapeutics, Inc. Investors of the Pending Lead Plaintiff Deadline – March 4, 2025 - GlobeNewsWire
- 7 months ago - Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC - PRNewsWire
- 7 months ago - Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights – RVNC - GlobeNewsWire
- 7 months ago - Crown Laboratories Completes Acquisition of Revance Therapeutics - Business Wire
- 7 months ago - Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics - PRNewsWire
- 7 months ago - Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer - PRNewsWire
- 7 months ago - Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline - PRNewsWire